Renowned Brain Surgeons Validate LuminusMicro Devices; New Manufacturing Breakthroughs Reduce Production Costs While Global Medtech Firms Compete for Lead Investor Positions

Q3 2024

Two of the foremost brain surgeons in the U.S. independently met with LuminusMicro CEO Russ Meek to experience our cutting-edge technology firsthand. Each was astounded by our devices’ unparalleled HD image quality, intuitive surgical navigation, and their ability to deliver precisely targeted treatments at an unprecedented “micro-scale.”

Both surgeons confirmed that LuminusMicro devices are not only a fraction of the size but also a fraction of the cost of the most advanced devices on the market today. They each identified groundbreaking procedural opportunities for LuminusMicro within neurosurgery and multiple surgical fields, including our initial target market—ENT surgery. For more information, please contact management.

Manufacturing Breakthroughs

Recognizing the immense market potential and robust patent portfolio of LuminusMicro, leading global manufacturing firms have initiated in-person visits with our engineers and management. They are presenting their most innovative designs and competitive pricing for key components, vying to be integrated into LuminusMicro products.

Additionally, a top-tier medical device illumination company developed a custom solution that simplifies the installation of LuminusMicro’s illumination subsystem and significantly reduces production costs. This development marks a monumental breakthrough for LuminusMicro in terms of profitability and scalability, solidifying a strategic alliance with another leading global producer.

Global Medtech Firms Compete for Lead Investor Positions

In recent weeks, four leading medtech firms have completed extensive due diligence on LuminusMicro as part of their consideration for strategic partnerships. Fully convinced of our potential, they have each entered negotiations for direct investments to expedite the LuminusMicro launch.

One of these firms is an East Coast medical device venture capital group, bringing executive talent and industry connections that will further bolster our accomplished team. The other three are premier medical manufacturers that have historically ceased investing in new medical technologies, let alone offering production space.

This level of industry validation is unparalleled. We are carefully evaluating the benefits of these potential investments as an adjunct to private funding sources, which could allow us to engage these firms as independent contractors. This approach would maintain our flexibility to collaborate with multiple firms and facilities, supporting the high demand for LuminusMicro devices, expanding our application portfolio across all surgical markets, and forming strategic partnerships to maximize shareholder returns.